A Randomized Phase IIB Open Label Study of Nivolumab in combination with Ipilimumab versus Bevacizumab in Adult Subjects with Recurrent Glioblastoma (GBM)
Clinical Trial Grant
Awarded By
The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership
Start Date
February 1, 2014
End Date
January 31, 2021
Awarded By
The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership
Start Date
February 1, 2014
End Date
January 31, 2021